巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Sensei Biotherapeutics

    SNSE
    2.045
    0.190
    8.71%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Sensei Biotherapeutics - 延遲價格・最後更新於 24/06 12:15
    最高位
    2.330
    最低位
    2.005
    開市價
    --
    前收市價
    2.240
    成交量(千)
    20.35
    成交額(百萬)
    0.31
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    62.64
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    12.370 - 1.450
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Sensei Biotherapeutics
    證券代碼
    SNSE.US
    所屬板塊
    Biotechnology
    公司業務
    Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response.
    發行量
    30682813
    公司總部
    451 D Street, Suite 710
    公司網址
    https://www.senseibio.com
    公司電郵
    info@senseibio.com
    公司電話
    +1 240 243-8000
    暫無內容

    關於

    Sensei Biotherapeutics(SNSE.US)所屬的行業板塊為Biotechnology。
    Sensei Biotherapeutics Inc is a clinical-stage immunotherapy company. It is engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer. The company's ImmunoPhage platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused, and coordinated innate and adaptive immune response.
    詳細公司背景可參考: https://www.senseibio.com